Validação externa do modelo HCM Risk-Kids para predizer morte cardíaca súbita na cardiomiopatia hipertrófica pediátrica.
17 Fev, 2022 | 14:57h
Comentário no Twitter
Check out #EJPC first external validation of the HCM Risk-Kids model https://t.co/EWaiApaxN5 #hypertrophic #cardiomyopathy #genetics #suddendeath #SCD @jodieingles27 @CSHeartResearch @CarolynHoMD @RumanaOmar @jpkaski @m_piepoli @SilCastelletti @paolo_emilio @EAPCPresident pic.twitter.com/rOVk1ynwWl
— European Society of Cardiology Journals (@ESC_Journals) January 2, 2022